Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hachiro Sugimoto

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|August 31, 2004
[Scope and limitations of acetylcholinesterase inhibitors]Hachiro Sugimoto
Chemico-Biological Interactions|June 26, 2008
The new approach in development of anti-Alzheimer's disease drugs via the cholinergic hypothesisHachiro Sugimoto
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 8, 2010
[Development of anti-Alzheimer's disease drug based on beta-amyloid hypothesis]Hachiro Sugimoto
Biological & Pharmaceutical Bulletin|October 5, 2019
The Additive Effects of Low Dose Intake of Ferulic Acid, Phosphatidylserine and Curcumin, Not Alone, Improve Cognitive Function in APPswe/PS1dE9 Transgenic MiceMichiaki Okuda, Yuki Fujita, Hachiro Sugimoto
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 10, 2015
[Fundamental study of memory impairment and non-cognitive behavioral alterations in APPswe/PS1dE9 mice]Nobuhiko Taniuchi, Tetsuhiro Niidome, Hachiro Sugimoto
Journal of Receptor and Signal Transduction Research|February 17, 2010
Biological characterization of ADAM22 variants reveals the importance of a disintegrin domain sequence in cell surface expressionKoji Sagane, Hachiro Sugimoto, Akinori Akaike
International Journal of Biological Sciences|November 1, 2008
LGI1 and LGI4 bind to ADAM22, ADAM23 and ADAM11Koji Sagane, Yasushi Ishihama, Hachiro Sugimoto
Journal of Alzheimer'S Disease : JAD|December 17, 2016
Decrease of Amyloid-β Levels by Curcumin Derivative via Modulation of Amyloid-β Protein Precursor TraffickingRina Kotani, Yasuomi Urano, Hachiro Sugimoto, et al.
European Journal of Medicinal Chemistry|August 4, 2014
Development of dual targeting inhibitors against aggregations of amyloid-β and tau proteinShinichiro Fuse, Keisuke Matsumura, Yuki Fujita, et al.
International Immunology|March 12, 2011
Anti-arthritic effect of E3 ubiquitin ligase, c-MIR, expression in the jointsMasayasu Toyomoto, Satoshi Ishido, Nobuyuki Miyasaka, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|August 31, 2004
[Scope and limitations of acetylcholinesterase inhibitors]Hachiro Sugimoto
Chemico-Biological Interactions|June 26, 2008
The new approach in development of anti-Alzheimer's disease drugs via the cholinergic hypothesisHachiro Sugimoto
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 8, 2010
[Development of anti-Alzheimer's disease drug based on beta-amyloid hypothesis]Hachiro Sugimoto
Biological & Pharmaceutical Bulletin|October 5, 2019
The Additive Effects of Low Dose Intake of Ferulic Acid, Phosphatidylserine and Curcumin, Not Alone, Improve Cognitive Function in APPswe/PS1dE9 Transgenic MiceMichiaki Okuda, Yuki Fujita, Hachiro Sugimoto
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 10, 2015
[Fundamental study of memory impairment and non-cognitive behavioral alterations in APPswe/PS1dE9 mice]Nobuhiko Taniuchi, Tetsuhiro Niidome, Hachiro Sugimoto
Journal of Receptor and Signal Transduction Research|February 17, 2010
Biological characterization of ADAM22 variants reveals the importance of a disintegrin domain sequence in cell surface expressionKoji Sagane, Hachiro Sugimoto, Akinori Akaike
International Journal of Biological Sciences|November 1, 2008
LGI1 and LGI4 bind to ADAM22, ADAM23 and ADAM11Koji Sagane, Yasushi Ishihama, Hachiro Sugimoto
Journal of Alzheimer'S Disease : JAD|December 17, 2016
Decrease of Amyloid-β Levels by Curcumin Derivative via Modulation of Amyloid-β Protein Precursor TraffickingRina Kotani, Yasuomi Urano, Hachiro Sugimoto, et al.
European Journal of Medicinal Chemistry|August 4, 2014
Development of dual targeting inhibitors against aggregations of amyloid-β and tau proteinShinichiro Fuse, Keisuke Matsumura, Yuki Fujita, et al.
International Immunology|March 12, 2011
Anti-arthritic effect of E3 ubiquitin ligase, c-MIR, expression in the jointsMasayasu Toyomoto, Satoshi Ishido, Nobuyuki Miyasaka, et al.
Pageof 9